Combined Effect of Tryptophan Rich Diet and Acupuncture on Depression Related to Premenstrual Dysphoric Disorder
1 other identifier
interventional
39
0 countries
N/A
Brief Summary
Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome (PMS) affecting up to 8% of reproductive age women. It is characterized by physical and psychological symptoms that occur in the luteal phase of the menstrual cycle, prior to the onset of menses, and leads to negative impact on the psychosocial functioning of affected individuals. Selective serotonin reuptake inhibitors are usually used to treat PMDD but they have several side effects so it is important to use complementary treatment such as tryptophan-rich diet and acupuncture for women with PMDD . The purpose of the current study is to determine the combined effect of tryptophan-rich diet and acupuncture on depression related to premenstrual dysphoric disorder
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2023
CompletedFirst Posted
Study publicly available on registry
April 14, 2023
CompletedStudy Start
First participant enrolled
April 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2023
CompletedApril 14, 2023
April 1, 2023
2 months
March 30, 2023
April 12, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
The Premenstrual Symptoms Screening Tool (PSST)
It is a validated, simple, user-friendly screening tool to identify women who suffer from severe Premenstrual Syndrome (PMS) or Premenstrual Dysphoric Disorder (PMDD). It reflects and 'translates' categorical Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria into a rating scale with degrees of severity (Not at all, mild, moderate, severe). The scoring will be as follows: the following criteria must be present for a diagnosis of PMDD: * At least one of #1, #2, #3, and #4 is severe. * In addition at least four of #1 - #14 are moderate to severe. * At least one of A, B, C, D and E is severe.
Up to 2 months
Hamilton Depression Rating Scale (HDRS)
The HDRS (also known as the Ham-D) is the most widely used clinician-administered depression assessment scale. HRSD provides a reliable and valid assessment of depression. Method for scoring varies by version. For the HDRS17, a score of 0 - 9 is generally accepted to be within the normal range, 10 - 13 mild, 14-17 mild to moderate and \>17 moderate to severe
Up to 2 months
Secondary Outcomes (1)
Quality of Life Enjoyment and Satisfaction Questionnaire - short form
Up to months 2
Study Arms (3)
Tryptophan rich diet + vitamin B6 supplementation
EXPERIMENTALIt will include 13 participants suffering from premenstrual dysphoric disorder (PMDD) who will be treated by diet rich wit tryptophan (high protein diet) for 8 weeks in addition to vitamin B6 tablets 60 mg once/day, throughout two menstrual cycles, starting from the first day of their menstrual cycle
Acupuncture + Vitamin B6 supplementation
EXPERIMENTALIt will include 13 participants suffering from premenstrual dysphoric disorder (PMDD) who will be treated by acupuncture twice a week for 8 weeks, resulting in a total of 16 visits. Each visit, including initial care, needle application and needle retention, will last about 45 min. In addition to vitamin B6 tablet 60mg once/day, throughout two menstrual cycles, starts from the first day of their menstrual cycle
Acupuncture + Tryptophan rich diet + vitamin B6 supplementation
EXPERIMENTALIt will include 13 participants suffering from premenstrual dysphoric disorder (PMDD) who will be treated by diet rich with tryptophan (high protein diet) for 8 weeks and acupuncture twice a week for 8 weeks, resulting in a total of 16 visits. Each visit, including initial care, needle application and needle retention, will last about 45 min. In addition to vitamin B6 tablet 60mg once/day, throughout two menstrual cycles, starts from the first day of their menstrual cycle
Interventions
Tony disposable, single-use 0.20Ă—40 mm Chinese needles will be used. The needle penetrates the skin sufficiently to reach the required depth and elicit de qi. The needles remains for 30 min, with gentle rotational movements applied three times during the session.
All participants in both groups (A and C) will be treated by high protein foods rich with tryptophan including: chicken , turkey, red meat, salmon, fish, tuna, beans, milk, cheese, seeds, nuts, egg, banana, kiwi, leafy greens, mushroom, broccoli and peas, etc. Total daily calorie intake will be calculated for each participant in both groups (A and C) before diet description. All females will serve the meals that met their required kilocalorie levels and physical activity levels so that the participants will not lose weight, feel hungry or be over-fed.
All participants in all groups (A, B and C) will receive a tablet of vitamin B6 60mg once/day for 8 weeks, starting from the first day of their menstrual cycle, throughout two menstrual cycles.
Eligibility Criteria
You may qualify if:
- All females will be clinically diagnosed with premenstrual dysphoric disorder (PMDD) as confirmed and referred from the gynaecologist.
- All females will be firstly assessed by Hamilton Depression rating scale (HDRS) for two months to confirm depression related to PMDD before participating in the study.
- Their ages will be ranged from 20 to 30 years.
- Their BMI will be ranged from 20 to 25 kg/m.
- Being virgin.
- Having regular menstruation for the last 6 months (every 28- 35 days with no intermittent bleeding).
- All females have a sedentary lifestyle.
- Voluntary acceptance of participation in the study
You may not qualify if:
- Using hormonal contraception (such as oral contraceptives and injections).
- Menstrual irregularity.
- Using diuretics or psychiatric medications.
- Using chronic non-steroidal anti-inflammatory drugs.
- Pre-diagnosed with any other psychological problems not related to PMDD.
- Follow any exercise programs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Demonstrator at Physical Therapy department of Women's Health , Faculty of Physical Therapy, Horus University
Study Record Dates
First Submitted
March 30, 2023
First Posted
April 14, 2023
Study Start
April 25, 2023
Primary Completion
June 25, 2023
Study Completion
July 25, 2023
Last Updated
April 14, 2023
Record last verified: 2023-04